Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
304.49
-11.43 (-3.62%)
At close: Dec 5, 2025, 4:00 PM EST
304.20
-0.29 (-0.10%)
After-hours: Dec 5, 2025, 7:49 PM EST
Insulet Employees
Insulet had 3,900 employees as of December 31, 2024. The number of employees increased by 900 or 30.00% compared to the previous year.
Employees
3,900
Change (1Y)
900
Growth (1Y)
30.00%
Revenue / Employee
$646,615
Profits / Employee
$63,128
Market Cap
21.42B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3,900 | 900 | 30.00% |
| Dec 31, 2023 | 3,000 | 400 | 15.38% |
| Dec 31, 2022 | 2,600 | 300 | 13.04% |
| Dec 31, 2021 | 2,300 | 400 | 21.05% |
| Dec 31, 2020 | 1,900 | 550 | 40.74% |
| Dec 31, 2019 | 1,350 | 181 | 15.48% |
| Dec 31, 2018 | 1,169 | 312 | 36.41% |
| Dec 31, 2017 | 857 | 217 | 33.91% |
| Dec 31, 2016 | 640 | -7 | -1.08% |
| Dec 31, 2015 | 647 | 128 | 24.66% |
| Dec 31, 2014 | 519 | 41 | 8.58% |
| Dec 31, 2013 | 478 | -60 | -11.15% |
| Dec 31, 2012 | 538 | -38 | -6.60% |
| Dec 31, 2011 | 576 | 266 | 85.81% |
| Dec 31, 2010 | 310 | 34 | 12.32% |
| Dec 31, 2009 | 276 | -18 | -6.12% |
| Dec 31, 2008 | 294 | 47 | 19.03% |
| Dec 31, 2007 | 247 | -47 | -15.99% |
| Dec 31, 2006 | 294 | 47 | 19.03% |
| Dec 31, 2005 | 247 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PODD News
- 2 days ago - Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience - Business Wire
- 10 days ago - Artisan International Small-Mid Fund Q3 2025 Contrarianism Pays Off - Seeking Alpha
- 15 days ago - Insulet Corporation (PODD) Analyst/Investor Day Transcript - Seeking Alpha
- 16 days ago - Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day - Business Wire
- 24 days ago - PODD Vs. Intuitive Surgical: This Underdog Might Just Win - Forbes
- 4 weeks ago - Insulet Corporation (PODD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Insulet tops quarterly estimates on demand for wearable insulin pumps - Reuters
- 4 weeks ago - Insulet Reports Third Quarter 2025 Results - Business Wire